Ziad2022-11-25T14:06:07-05:00Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the signing of a partnership and exclusive reseller agreement with GLG Pharma, LLC (“GLG”). Read more >>
Ziad2022-11-25T14:06:07-05:00Leading skin microbiome company AOBiome announced today the launch of its Phase 2B trial using its first-in-class live bacteria to treat acne. Phase 2B marks the advancement from the company's successful Phase 1B/2A dose-ranging safety study, which resulted in no serious adverse events and no difference in adverse events between treatment and vehicle groups. Read more >>
Ziad2022-11-25T14:06:07-05:00ZetrOZ Systems, LLC, announced today that the company’s innovative FDA cleared wearable-active ultrasound device – called sam® Sport – is now used widely by professional athletic trainers and physiotherapists in the NFL, NBA, NHL, MLS, MLB and USA Teams. Read more >>
Ziad2022-11-25T14:06:07-05:00BUILD will award Mic Williams and Boston Harbor Angels the “BUILD Friend of the Year Award” as part of their 5-Year Anniversary BUILDFest Gala, which will be held on Wednesday October 19th from 5:30-9:30 pm at the Boston Convention Center.
BUILD and Boston Harbor Angels have partnered and are very happy to be able to bring more resources to help at-risk youth. Read more >>
Ziad2022-11-25T14:06:07-05:00Premama®, the first nationwide line of natural powdered drink mixes and soft chews to support complete maternity wellness from preconception through pregnancy and beyond, today announced a record retail expansion, experiencing rapid growth from 1,100 to 7,700 retail distribution points since April 2015 and a significant 360% growth in sales from August 2015 to August 2016. Spearheading maternity wellness as a retail category, Premama has pioneered industry awareness and consumer demand with products for the entire maternity journey. Read more...
Ziad2022-11-25T14:06:07-05:00The Academy of Management Entrepreneurship Division has awarded the Dedication To Entrepreneurship Award to Babson Vice Provost of Global Entrepreneurial Leadership Candy Brush. Read more >>
Ziad2022-11-25T14:06:07-05:00Siamab Therapeutics, Inc., a biotechnology company developing novel cancer immunotherapies, today announced new pre-clinical data that showed its novel ST1 antibody drug conjugates (ADCs) target chemoresistant ovarian cancer cells and demonstrate strong efficacy in ovarian cancer models. These data were presented at the American Association for Cancer Research (AACR)’s 11th Biennial Ovarian Cancer Research Symposium 2016 in Seattle, Wash., on Monday, Sept. 12, 2016. Read more >>
Ziad2022-11-25T14:06:07-05:00llergan plc (NYSE: AGN), a leading global pharmaceutical company, and RetroSense Therapeutics LLC, a private, clinical-stage biotechnology company focused on novel gene therapy approaches to restore vision in patients suffering from blindness, today announced that Allergan has acquired substantially all of the assets of RetroSense in an all-cash transaction. Under the terms of the transaction, Allergan has paid RetroSense a $60 million upfront payment, and has agreed to potential regulatory and commercialization milestone payments related to its lead development...
Ziad2022-11-25T14:06:07-05:00BUILDFest Gala & Student Business Expo will be on Wednesday, October 19. Our own Mic Williams, Founder of Boston Harbor Angels, will be honored with BUILD Friend of the Year. ! Register now >>
Ziad2022-11-25T14:06:07-05:00Martin Lowenthal, MSIM, CLU®, ChFC®, RICP®, CLTC®, a Financial Representative of The Bulfinch Group, has passed the rigorous American College certification of Retirement Income Certified Professional, an advanced designation. Martin is only the second Bulfinch Group associate to have earned this prestigious designation.
This new designation from The American College creates strategies for Advisors who are focused on the needs of the thousands of Americans reaching age 65 who need guidance in obtaining sustainable retirement income. “Martin Lowenthal’s accomplishment in obtaining...
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.